Study Purpose:
This research is designed to augment the understanding of amyotrophic lateral sclerosis (ALS) by looking at skin cells from people with genetically confirmed familial ALS, as well as those from healthy individuals. Once the skin cells have been grown in the laboratory, they will be used to generate induced pluripotent stem cells, which will be made into nerve cells. Scientists will then be able to study these cells to learn more about ALS and potential treatments.
Study Status:
Not recruiting
Disease:
Amyotrophic Lateral Sclerosis (ALS) , Familial ALS
Study Type:
Observational
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Nicholas Maragakis, MD, Johns Hopkins University Jeffrey Rothstein, MD, PhD, Johns Hopkins University
Clinicaltrials.gov ID:
Neals Affiliated?
Yes
Coordinating Center Contact Information
Johns Hopkins University
Baltimore, Maryland, 21287 United States
Study Sponsor:
NIH
Estimated Enrollment:
25
Estimated Study Start Date:
09 / 30 / 2009
Estimated Study Completion Date:
08 / 31 / 2011
Posting Last Modified Date:
05 / 09 / 2019
Date Study Added to neals.org:
05 / 09 / 2019
Johns Hopkins University
Baltimore, Maryland
21287
United States